The cryptocurrency bull run is underway, and investors still have time to stack a few extra bucks before Christmas. Different cryptocurrency sectors are expected to have their own dedicated periods of prolonged bullish momentum, including AI coins like Injective, though some cryptocurrencies such as memes and layer-1’s like Solana could rally consistently throughout 2024-2025.
DEX coins typically perform well during market peaks, when retailers are loose with their money and new shiny coins are being unveiled on a weekly basis. With many parabolic rallies yet to come in this bull run, analysts have identified Lunex Network as the premier go-to DEX due to the platform’s immense cross-chain capabilities and accessibility. Here’s the rundown.
Solana On The Verge Of Another All-Time High As Hype Ramps Up In The Market
Solana has outperformed market projections in Q4, crossing the $250 threshold and securing its spot as the fourth-largest cryptocurrency. With a new all-time high of $263, Solana’s impressive recovery from bear market lows and the FTX scandal highlights its strength and growing investor confidence, as meme degens take advantage of Solana’s low gas fees and speedy transactions with decentralized applications like pump.fun.
Analysts are optimistic about Solana’s trajectory, suggesting it could reach $300-400 in the near future. Bitcoin’s recovery could further fuel Solana’s rise, alongside an imminent altcoin season that will likely drive higher network activity to Solana. As Solana edges closer to surpassing another new all-time high, Solana could evolve to eventually usurp Ethereum in the long-term.
Injective Poised To Rally During A Projected AI Season In 2025
Injective has recently shown strong performance, emerging as one of crypto’s premier AI coins with a notable 50% monthly upsurge. This rise for Injective follows broader bullish market trends, though AI coins are yet to fully have their time in the limelight.
Most analysts agree that there will be at least one AI season in this cycle. If this rings true, Injective remains a solid speculative pick for 2024-2025, though some analysts believe that Injective will suffer through a minor correction in the short-term. Updates and new developments such as Injective unveiling an iAgent SDK to automate blockchain tasks with AI bode well for Injective’s long-term outlook, and Injective harbors potential to net 10x returns in 2025.
Get In Soon Before The Bull Run: Why Lunex Network Could Be The Next Big Thing
With an anticipated bull market on the horizon, Lunex Network is drawing significant attention for its strong fundamentals and user-friendly design. The platform simplifies the onboarding process by removing KYC requirements and eliminating the need for external wallets like MetaMask or PhantomWallet, delivering a smooth and hassle-free swapping experience.
Powered by advanced smart contract technology, Lunex Network enables seamless trading across more than 50,000 assets while keeping transaction fees low. This innovative approach ensures fast and cost-effective trades, rendering it an appealing choice for many different users.
Lunex Network also offers a competitive staking system with APYs of up to 18%. Supporting popular cryptocurrencies like Solana and Injective, the platform provides diverse options to cater to a wide range of staking preferences.
Currently priced at $0.0033, Lunex Network is positioned for significant growth as the bull market approaches. Early investors could see impressive returns as soon as December, making this the perfect time to acquire LNEX tokens before the subsequent presale stage.
You can find more information about Lunex Network (LNEX) here:
Website: https://lunexnetwork.com
Socials: https://linktr.ee/lunexnetwork
Disclaimer: This is a paid release. The statements, views and opinions expressed in this column are solely those of the content provider and do not necessarily represent those of Bitcoinist. Bitcoinist does not guarantee the accuracy or timeliness of information available in such content. Do your research and invest at your own risk.
